Thozalinone

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Thozalinone
Thozalinone.svg
Clinical data
Routes of
administration
Oral
ATC code none
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
Synonyms Tozalinone, Thozalinon
CAS Number 655-05-0 N
PubChem (CID) 12602
ChemSpider 12082 YesY
UNII 68X5932947 YesY
KEGG D06115 YesY
Chemical and physical data
Formula C11H12N2O2
Molar mass 204.225 g/mol
3D model (Jmol) Interactive image
Chirality Racemic mixture
 NYesY (what is this?)  (verify)

Thozalinone (USAN) (brand name Stimsen; former developmental code name CL-39808) is a psychostimulant that has been used as an antidepressant in Europe.[1][2][3][4][5] It has also been trialed as an anorectic.[6] Thozalinone is described as a "dopaminergic stimulant",[7] and likely acts via inducing the release of dopamine and norepinephrine similarly to its analogues pemoline and aminorex.[2][8][9]

See also[edit]

References[edit]

  1. ^ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 435–. ISBN 978-1-4757-2085-3. 
  2. ^ a b Greenblatt EN, Osterberg AC (July 1965). "Some pharmacologic properties of thozalinone, a new excitant". Toxicology and Applied Pharmacology. 7 (4): 566–78. doi:10.1016/0041-008X(65)90042-6. PMID 4378772. 
  3. ^ Dictionary of organic compounds. London: Chapman & Hall. 1996. ISBN 0-412-54090-8. 
  4. ^ Merck index on CD-ROM: Windows. London: Chapman & Hall EPD. 1998. ISBN 0-412-82910-X. 
  5. ^ Gallant DM, Bishop MP, Scrignar CB, Hornsby L, Moore B, Inturrisi BB (December 1966). "A double-blind study of thozalinone (C1 39,808) in depressed outpatients". Current Therapeutic Research, Clinical and Experimental. 8 (12): 621–2. PMID 4962734. 
  6. ^ Leite AC, Liepen LL, Costa VP (September 1971). "[Clinical trial of Stimsem Thozalinone in the treatment of obese patients]". Revista Brasileira De Medicina (in Portuguese). 28 (9): 475–8. PMID 5139648. 
  7. ^ Yen-koo, H. C.; Balazs, T. (2015). "Detection of Dopaminergic Supersensitivity Induced by Neuroleptic Drugs in Mice". Drug and Chemical Toxicology. 3 (2): 237–247. doi:10.3109/01480548009108286. ISSN 0148-0545. PMID 6112126. 
  8. ^ Yen-Koo HC, Balazs T (1980). "Detection of dopaminergic supersensitivity induced by neuroleptic drugs in mice". Drug and Chemical Toxicology. 3 (2): 237–47. doi:10.3109/01480548009108286. PMID 6112126. 
  9. ^ Yen-Koo HC, Davis DA, Balazs T (1985). "Inhibition of dopaminergic agonist-induced gnawing behavior by neuroleptic drugs in mice". Drug and Chemical Toxicology. 8 (6): 495–502. doi:10.3109/01480548509041072. PMID 2868876.